Aprogen Pharmaceuticals Inc (003060) — Long-term Investment Intensity
Aprogen Pharmaceuticals Inc (003060) has a Long-term Investment Intensity of 25.2% as of December 2019. Long-term investments of ₩91.97 Billion represent 25.2% of total assets of ₩365.28 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check Aprogen Pharmaceuticals Inc liquidity resilience to evaluate the company's liquid asset resilience ratio.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Aprogen Pharmaceuticals Inc Long-term Investment Intensity (2013–2019)
This chart shows how Aprogen Pharmaceuticals Inc's Long-term Investment Intensity has evolved across 7 annual periods from 2013 to 2019. As of December 2019, the intensity stands at 25.2%, reflecting long-term investments of ₩91.97 Billion against total assets of ₩365.28 Billion KRW. For the complete balance sheet picture, see Aprogen Pharmaceuticals Inc total assets.
Annual Long-term Investment Intensity for Aprogen Pharmaceuticals Inc (2013–2019)
The table below presents the year-by-year Long-term Investment Intensity for Aprogen Pharmaceuticals Inc from 2013 to 2019, covering 7 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read Aprogen Pharmaceuticals Inc total liabilities for a breakdown of total debt and financial obligations.
| Year | LT Investment Intensity | LT Investments (KRW) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2019 | 25.2% | ₩91.97 Billion | ₩365.28 Billion | ▼ -24.4 pp |
| 2018 | 49.5% | ₩107.52 Billion | ₩217.06 Billion | ▲ +9.8 pp |
| 2017 | 39.7% | ₩62.88 Billion | ₩158.27 Billion | ▲ +32.6 pp |
| 2016 | 7.2% | ₩9.21 Billion | ₩128.69 Billion | ▲ +6.0 pp |
| 2015 | 1.2% | ₩1.02 Billion | ₩85.22 Billion | ▼ -6.3 pp |
| 2014 | 7.5% | ₩6.33 Billion | ₩84.83 Billion | ▲ +0.2 pp |
| 2013 | 7.3% | ₩5.69 Billion | ₩78.26 Billion | — |